Clinical observations show that older patients do not tolerate high-dose ch
emoradiotherapy as well as younger patients, It is unclear whether this is
due to age-related differences in their responses to hematopoietic injury o
r to differential toxicities to other organs. In the present study, 6 young
(0.5 years) and 6 elderly (8 years) dogs were challenged with 7 repeated n
onlethal doses of 50 or 100 cGy total body irradiation (TBI) each (total 55
0 cGy), and 21 days of recombinant canine granulocyte-colony stimulating fa
ctor (rcG-CSF) after the last TBI dose. Recoveries of absolute neutrophil,
platelet, and lymphocyte counts after each TBI dose, responses to rcG-CSF t
reatment, and telomere lengths in neutrophils were compared before and afte
r the study. No differences were found in recoveries of neutrophils, platel
ets, or in responses to rcG-CSF among young and old dogs, in contrast, reco
veries were suggestively worse in younger dogs. After rcG-CSF, platelet rec
overies were poor in both groups compared with previous platelet recoveries
(P < .01), Consequently, 2 old and 3 young dogs were euthanized because of
persistent thrombocytopenia and bleeding. At the study's completion, marro
w cellularities and peripheral blood counts of the remaining young and elde
rly dogs were equivalent. The telomere lengths in both groups were signific
antly reduced after the study versus beforehand (P = .03), but the median a
ttritions of telomeres were not different. It was concluded that aging does
not appear to affect hematopoietic cell recoveries after repeated low-dose
TBI, suggesting that poor tolerance of radiochemotherapy regimens in older
patients may be due to nonhematopoietic organ toxicities rather than age-r
elated changes in hematopoietic stem cells reserves. (C) 2001 by The Americ
an Society of Hematology.